Our QTc Workshop was a Huge Success!

Posted:
1
October 2004

The QTc workshop hosted by Richmond Pharmacology on 29th September was deemed a huge success. Representatives from top pharmaceutical companies gathered at St George's Hospital to enjoy first class seminars given by world leading experts in cardiology.Jörg Täubel, Managing Director of Richmond Pharmacology began the proceedings by welcoming guests and introducing the speakers for the day.Professor John Camm, Chairman of the Department of Cardiac and Vascular Sciences at St George's Hospital Medical School, the first to speak, defined the QT interval and its clinical relevance. He later provided an insight into the factors that influence the QT interval.Dr Elijah Behr from St George's Hospital Medical School gave a detailed presentation on the congenital syndromes of abnormal ventricular repolarisation. Dr Behr also reflected on the important role that pharmacogenomics will play in the development of drugs in the near future.Professor Marek Malik, also from St George's Hospital Medical School took to the rostrum after coffee to talk about the correction or control of the QT interval for heart rate. Later in the day, Professor Malik returned to give an entertaining presentation on how the QT interval should be measured and the possible implications of all these factors in Study Design.After a delicious buffet lunch, Dr Rashmi Shah from the MHRA, gave an insightful presentation on the regulatory aspects of drug induced QTinterval prolongation, and finished the workshop with a talk entitled The Definitive QT Study, which highlighted the importance of inclusion of such studies in adequate drug development programmes.Initial feedback from those that attended the workshop has been outstanding, everyone benefited from the highly educational and enjoyable day.Richmond Pharmacology continues to work closely with St George's Hospital Medical School to ensure we provide the expertise required for QTc studies. For more information on Richmond Pharmacology's QTc capabilities, please visit our services page.The event was filmed and will be available as a DVD pack in November.

Latest news

Upcoming Event

On Helix, Transforming new medicine discovery

13-14 July 2020
Richmond Pharmacology will be showcasing a presentation on Adaptive Early Phase Clinical Trials as part of the ON HELIX digital event.
View event

COVID-19 – External Monitoring Guidelines

July 1, 2020
Richmond Pharmacology is constantly assessing health and safety risks posed by COVID-19 and is regularly reviewing Public Health England guidance.
Read more

First transdermal patch to treat schizophrenia hits market

March 18, 2020
The US Food and Drug Administration (FDA) has officially approved a transdermal patch to treat schizophrenia developed by Hisamitsu Pharmaceutical Co following successful
Read more

Statement: COVID-19

March 23, 2020
Richmond Pharmacology are continuously risk-assessing our activity in relation to the COVID-19 crisis and we are evaluating what activity can continue, what precautions need to be put in place and what needs to be suspended.
Read more